Работы, цитирующие эту работу

Работ: 1

1. Comment on “Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study”

   Shobana Chandrasekar, M.K. Rohith Krishnan, Umesh Kumar

   СтатьяMultiple Myeloma Research and TreatmentsJournal of the Formosan Medical Association2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.021129